149 related articles for article (PubMed ID: 6457019)
41. Neuropathy of nitroimidazole radiosensitizers: clinical and pathological description.
Wasserman TH; Nelson JS; VonGerichten D
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1725-30. PubMed ID: 6237085
[TBL] [Abstract][Full Text] [Related]
42. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
Siemann DW
Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
[TBL] [Abstract][Full Text] [Related]
43. Treatment of bladder carcinoma with irradiation combined with misonidazole.
Papavasiliou C; Yiogarakis D; Davillas N; Seretakis L; Pappas J; Licourinas M; Theodorou C; Stathopoulos P; Katsoyianni C; Thanos A
Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1631-3. PubMed ID: 6358156
[TBL] [Abstract][Full Text] [Related]
44. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170).
Murayama C; Suzuki A; Suzuki T; Miyata Y; Sakaguchi M; Tanabe Y; Tanaka N; Mori T
Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):575-81. PubMed ID: 2528527
[TBL] [Abstract][Full Text] [Related]
45. Genotoxic and cytocidal effects of three electron-affinic sensitizers on hypoxic and aerated mammalian cells.
Geard CR; Spunberg JJ; Rutledge-Freeman M; Harding T
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):713-7. PubMed ID: 6213590
[No Abstract] [Full Text] [Related]
46. A comparison of the cytological effects of three hypoxic cell radiosensitizers.
Spunberg JJ; Geard CR; Rutledge-Freeman MH
Int J Radiat Oncol Biol Phys; 1982 Jul; 8(7):1207-15. PubMed ID: 6214532
[TBL] [Abstract][Full Text] [Related]
47. Testing of hypoxic cell radiosensitizers in vivo.
Denekamp J
Cancer Clin Trials; 1980; 3(2):139-48. PubMed ID: 7428137
[TBL] [Abstract][Full Text] [Related]
48. Cytocidal effects of misonidazole, Ro 03-8799, and RSU-1164 on euoxic and hypoxic BP-8 murine sarcoma cells at normal and elevated temperatures.
Hofer KG; Lakkis M; Hofer MG
Cancer; 1989 Apr; 63(8):1501-8. PubMed ID: 2924258
[TBL] [Abstract][Full Text] [Related]
49. Sensitizers and radiation dose fractionation: results and interpretations.
Hill RP
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1049-54. PubMed ID: 2943705
[TBL] [Abstract][Full Text] [Related]
50. [Clinical study on radiotherapy in combination with misonidazole].
Ono K; Takahashi M; Dodo Y; Abe M
Nihon Gan Chiryo Gakkai Shi; 1983 Aug; 18(5):1189-99. PubMed ID: 6663172
[No Abstract] [Full Text] [Related]
51. The pharmacokinetics and tumor and neural tissue penetrating properties of SR-2508 and SR-2555 in the dog--hydrophilic radiosensitizers potentially less toxic than misonidazole.
White RA; Workman P; Brown JM
Radiat Res; 1980 Dec; 84(3):542-61. PubMed ID: 6450431
[No Abstract] [Full Text] [Related]
52. Care with radiosensitizers.
Adams GE; Dische S
Br J Radiol; 1979 Nov; 52(623):920-2. PubMed ID: 519155
[No Abstract] [Full Text] [Related]
53. [Cancer and radiotherapy. (4). Hypoxic cell sensitizers and hyperthermia combined with radiation in cancer treatment].
Abe M; Takahashi M; Ono K; Hiraoka M
Iyodenshi To Seitai Kogaku; 1982 Jun; 20(3):203-9. PubMed ID: 6759728
[No Abstract] [Full Text] [Related]
54. The treatment of locally advanced head and neck cancer with misonidazole, hyperbaric oxygen and irradiation: an interim report.
Sealy R; Cridland S
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1721-3. PubMed ID: 6384161
[TBL] [Abstract][Full Text] [Related]
55. Reduced fractionation and the potential of hypoxic cell sensitizers in irradiation of malignant epithelial tumors.
Cox JD; Byhardt RW; Komaki R; Greenberg M
Int J Radiat Oncol Biol Phys; 1980 Jan; 6(1):37-40. PubMed ID: 6245044
[No Abstract] [Full Text] [Related]
56. The effect of a hypoxic cell sensitizer on cancer radiotherapy: an analysis by a model.
Okumura Y; Okajima S
Strahlentherapie; 1984 Oct; 160(10):620-3. PubMed ID: 6495356
[TBL] [Abstract][Full Text] [Related]
57. Clinical experience with intravenous misonidazole for carcinoma of the esophagus: results in attempting radiosensitization of each fraction of exposure.
Schwade JG; Kinsella TJ; Kelly B; Rowland J; Johnston M; Glatstein E
Cancer Invest; 1984; 2(2):91-5. PubMed ID: 6733563
[TBL] [Abstract][Full Text] [Related]
58. Radiation sensitization studies in Japan.
Sugahara T; Nakatsugawa S
Cancer Treat Rev; 1981 Mar; 8(1):51-61. PubMed ID: 7018682
[No Abstract] [Full Text] [Related]
59. A report on misonidazole in randomized trial in locally advanced head and neck cancer.
Sealy R; Williams A; Cridland S; Stratford M; Minchinton A; Hallet C
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):339-42. PubMed ID: 7050035
[TBL] [Abstract][Full Text] [Related]
60. [Clinical testing of the radiosensitizer RO-07-0582 (misonidazole). Dose tolerance, toxicity and pharmacokinetic studies, preliminary report (author's transl)].
Bataini JP; Bernier J; de Narbonne J; Brugère J; Jaulerry C; Brunin F
Bull Cancer; 1978; 65(4):482-5. PubMed ID: 371710
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]